OWC Pharmaceutical Research Announces $750K Equity Purchase Agreement With Kodiak Capital Group

January 11, 2016 /PRNewswire/ —
OWC Pharmaceutical Research Corp. (OTC: OWCP), an
Israel-based pharmaceutical research company dedicated to the development of cannabinoid treatments, products and delivery technologies, today announced that it has entered into a
$750,000 equity purchase agreement (“Agreement”) with Kodiak Capital Group, LLC (“Kodiak”).

     (Logo: http://photos.prnewswire.com/prnh/20150311/734965-a )
     (Logo: http://photos.prnewswire.com/prnh/20150311/734965-b )

ORIGINAL SOURCE: Click Here to Continue Reading Article…